Gian Gandhi

573 total citations
17 papers, 420 citations indexed

About

Gian Gandhi is a scholar working on Psychiatry and Mental health, Health and Infectious Diseases. According to data from OpenAlex, Gian Gandhi has authored 17 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Health and 5 papers in Infectious Diseases. Recurrent topics in Gian Gandhi's work include Bipolar Disorder and Treatment (7 papers), Vaccine Coverage and Hesitancy (6 papers) and COVID-19 epidemiological studies (3 papers). Gian Gandhi is often cited by papers focused on Bipolar Disorder and Treatment (7 papers), Vaccine Coverage and Hesitancy (6 papers) and COVID-19 epidemiological studies (3 papers). Gian Gandhi collaborates with scholars based in United States, United Kingdom and Switzerland. Gian Gandhi's co-authors include E.T. Edgell, Ana Lowin, Emuella Flood, Dennis A. Revicki, Leah Kleinman, Patrick Lydon, Jean‐Marie Okwo‐Bele, Jos Vandelaer, Lizheng Shi and Logan Brenzel and has published in prestigious journals such as BMC Public Health, Vaccine and Bulletin of the World Health Organization.

In The Last Decade

Gian Gandhi

16 papers receiving 401 citations

Peers

Gian Gandhi
Hye Young Lee South Korea
Melissa Wardle United States
Emma Anderson United Kingdom
Belinda Davison Australia
Babatunde Adetunji United States
James L. Harmon United States
Hye Young Lee South Korea
Gian Gandhi
Citations per year, relative to Gian Gandhi Gian Gandhi (= 1×) peers Hye Young Lee

Countries citing papers authored by Gian Gandhi

Since Specialization
Citations

This map shows the geographic impact of Gian Gandhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gian Gandhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gian Gandhi more than expected).

Fields of papers citing papers by Gian Gandhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gian Gandhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gian Gandhi. The network helps show where Gian Gandhi may publish in the future.

Co-authorship network of co-authors of Gian Gandhi

This figure shows the co-authorship network connecting the top 25 collaborators of Gian Gandhi. A scholar is included among the top collaborators of Gian Gandhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gian Gandhi. Gian Gandhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Thornton, I. W. B., et al.. (2023). Public health emergency archetypes: a framework to guide efforts to ensure equitable access to medical countermeasures. BMJ Global Health. 8(5). e012436–e012436. 2 indexed citations
2.
Thornton, I. W. B., Paul Wilson, & Gian Gandhi. (2022). “No Regrets” Purchasing in a pandemic: making the most of advance purchase agreements. Globalization and Health. 18(1). 62–62. 6 indexed citations
3.
Thornton, I. W. B. & Gian Gandhi. (2022). Monkeypox: balancing response and future preparedness during a global public health emergency. BMJ Global Health. 7(10). e010644–e010644. 2 indexed citations
4.
Baker, Edward L., et al.. (2019). Shaping markets to benefit global health – A 15-year history and lessons learned from the pentavalent vaccine market. Vaccine X. 2. 100033–100033. 10 indexed citations
7.
Lydon, Patrick, Gian Gandhi, Jos Vandelaer, & Jean‐Marie Okwo‐Bele. (2014). Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?. Bulletin of the World Health Organization. 92(5). 382–384. 30 indexed citations
9.
Hecht, Robert & Gian Gandhi. (2008). Demand Forecasting for Preventive??AIDS Vaccines. PharmacoEconomics. 26(8). 679–697. 9 indexed citations
10.
Dardennes, Roland, Hélène Verdoux, Gian Gandhi, et al.. (2003). Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes. PharmacoEconomics. 21(15). 1081–1090. 27 indexed citations
11.
Kleinman, Leah, Ana Lowin, Emuella Flood, et al.. (2003). Costs of Bipolar Disorder. PharmacoEconomics. 21(9). 601–622. 177 indexed citations
12.
Dardennes, Roland, Hélène Verdoux, Gian Gandhi, et al.. (2003). [Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].. PubMed. 29(3 Pt 1). 248–53. 5 indexed citations
13.
Shi, Lizheng, M. Namjoshi, Gian Gandhi, et al.. (2002). Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. International Clinical Psychopharmacology. 17(5). 227–237. 54 indexed citations
14.
Löthgren, Mickael, et al.. (2002). PMH6 DIRECT MEDICAL COSTS FOR TREATMENT OF PATIENTS EXPERIENCING BIPOLAR DISORDER EPISODES IN THE UK. Value in Health. 5(6). 516–516. 1 indexed citations
15.
Dardennes, Roland, et al.. (2002). Frequency and hospitalisation-related costs of manic episodes in patients with bipolar I disorder in France. European Psychiatry. 17. 108–108. 1 indexed citations
16.
Shi, Lizheng, M. Namjoshi, Gian Gandhi, et al.. (2001). Olanzapine versus haloperidol: A prospective comparison of clinical and work status outcomes in bipolar disorder. European Neuropsychopharmacology. 11. S280–S280. 1 indexed citations
17.
Shi, Lizheng, M. Namjoshi, Gian Gandhi, et al.. (2001). Clinical and health-related quality of life outcomes associated with olanzapine in patients with bipolar disorder as compared with haloperidol. European Neuropsychopharmacology. 11. S277–S277. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026